Life Sciences
Home >> Views >> Life Sciences
Controllers Up Stakes In Fosun Pharma, Hongbaoli
Source£ºCCMR   Data£º2012-2-10

Nanjing Hongbaoli Corporation (002165) and Shanghai Fosun Pharmaceutical (Group) (600196) announced share buy backs by major shareholders, reports Shanghai Securities News, citing a company filing.

Jiangsu Baoyuan Investment, the largest shareholder of Hongbaoli, purchased 527,000 shares, or a 0.19 percent stake, at an average price of 11.24 yuan per share as it is optimistic about the future development prospects of the listed company.

Fosun Pharma said Fosun Group purchased 824,000 shares, or a 0.04 percent interest, yesterday. This brings the total shareholding of Fosun Group to 48.1 percent.

Fosun Group plans to up its stake by up to two percent within the next one year.


Related Hot
Copyright © 2012-2020  CCMR | China Ceidea Market Research Co., LTD  Inc. All rights reserved.
Add£ºRoom 406 Huide Building No 102 Hao Xian Road Yuexiu District Guangzhou Tel£º+86-020-28931413 +86 13503051005 
 BINWEB